Tag: <span>Egle Therapeutics</span>

Europe Legal Chronicle. November 3, 2021

Egle Therapeutics’ €40 Million Series A Funding Round

By Naoual Sadouqi

McDermott Will & Emery advised Egle Therapeutics on the deal. Gide advised the pool of investors, while Morgan, Lewis & Bockius advised Takeda Ventures. Egle Therapeutics, […]

Broccolini Investment Inc.’s C$60 Million Acquisition of 99 Acre Site

Eridan Communications’ US$46 Million Series B Funding

Dragonfly Energy’s Business Combination with Chardan NexTech Acquisition 2 Corp.

9ine Empreendimentos’ Acquisition of an additional 30% stake in Uberlândia Shopping Center

Cuotas Cencosud Serie XXI’s $13.9 Million Notes Offering

Medanito’s $ 20 Million Cash Tender Offering on 2016 Notes

CTP Group’s Acquisition of a Logistics Portfolio from 7R

MagaLoop’s €9 Million Series A Funding Round

Monterro’s Acquisition of TimeXtender

Canal Sugar Company’s Development of a Large-scale Agricultural Farm

Amethis, SPE Capital and EBRD’s Acquisition of a 95% Stake of GlobalCorp

Azure Power Global Limited’s $249 Million Rights Offering

Uniphore’s Acquisition of Colabo Inc

Al Seer Marine Supplies and BGN INT’s $135 Million Financing

Shibolet Group’s Sale of a Logistics Centre

Mayfield Childcare Limited’s $39.2 Million Acquisition of Genius Learning Group

Guangzhou S-Up Kids’ Dispute over Building Block Toy Patent Infringement Case

Zoomlion Heavy Industry Science and Technology’s Acquisition of Controlling Stake in ShenZhen RoadRover Technology

Dias Carneiro celebrates 20 years of operation

New member at the French – Argentine Chamber of Commerce and Industry: Zang, Bergel & Viñes Abogados

International law firm Ogier merges with Dublin-based Leman Solicitors

From SMP to YPOG: Business law firm with new name and expanded partner base

Federico Michele Sorrentino is the new Avocom’s Equity Partner

McDermott Bolsters Real Estate Transactions Firepower in New York and Chicago

Cleary Gottlieb Adds Two San Francisco Bay Area Partners

Studio Legale Bastianini Carnelutti and Schiavello & Co Studio Legale: a new alliance is born

Egle Therapeutics

Egle Therapeutics’ €40 Million Series A Funding Round